AB
OKUR

Amalgamated Bank’s OnKure Therapeutics OKUR Stock Holding History

Amalgamated Bank’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33
Closed -$1K – 3123
2024
Q1 		$1K Sell
33
-86
-72% -$1.42K ﹤0.01% 2942
2023
Q4 		$2K Sell
119
-10
-8% -$623 ﹤0.01% 2982
2023
Q3 		$10K Hold
129
– – ﹤0.01% 2902
2023
Q2 		$8K Buy
+129
New +$10.4K ﹤0.01% 2977
2022
Q2 		– Sell
-132
Closed -$4K – 3231
2022
Q1 		$4K Buy
+132
New +$7.39K ﹤0.01% 3041

Other funds holding OKUR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Amalgamated Bank's OKUR Position: Q2 2024 in Review

Amalgamated Bank sold out of OnKure Therapeutics (OKUR) in Q2 2024, closing a stake of 33 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in OKUR in Q1 2022 and held it in 5 quarters. The position peaked at $10K in Q3 2023. 66 funds tracked by Wall St. Rank hold OKUR as of Q2 2024.

  • Amalgamated Bank reported no remaining OnKure Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 33 OnKure Therapeutics shares in Q2 2024, an estimated $1K.
  • Amalgamated Bank first reported a position in OnKure Therapeutics in Q1 2022 and held it in 5 quarters.
  • Amalgamated Bank's OnKure Therapeutics position peaked at $10K in Q3 2023.
  • 66 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.